FIGURE 2. Overall survival. A, Overall survival rate was 91.3% in the PHRAC arm and 83.3% in the control arm at 3 years (P = 0.03). B, In stage II disease, the overall survival rate was 93.9% in the PHRAC arm and 90.0% in the control arm at 3 years (P = 0.07). C, In stage II disease, the overall survival rate was 87.7% in the PHRAC arm and 75.7% in the control arm at 3 years (P = 0.02).